Clinical trial
Utility of CAML as Diagnostic for Early Stage Lung Cancer
NCT03992183
Study timeline
Study start (actual)2019-05-21Date precision: day
Registry last updated2026-03-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Nodule, Multipleunresolved
Pulmonary Nodule, Solitaryunresolved
Interventions
Sponsors & collaborators
Fox Chase Cancer Centerlead sponsor
United States Department of Defensecollaborator
Creatv Microtech, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03992183 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.